Suzhou Highfine Biotech Co (SZSE:301393) Margin of Safety % (DCF Earnings Based): N/A (As of Jul. 19, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SZSE:301393 Suzhou Highfine Biotech Co Ltd SZSE:301393
92 GF Score
Price ¥60.06
GF Value ¥70.76
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Suzhou Highfine Biotech Co Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Suzhou Highfine Biotech Co's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

SZSE:301393 vs ZTS, UTHR: Margin of Safety % (DCF Earnings Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Suzhou Highfine Biotech Co's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Suzhou Highfine Biotech Co Margin of Safety % (DCF Earnings Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Suzhou Highfine Biotech Co's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Suzhou Highfine Biotech Co's Margin of Safety % (DCF Earnings Based) falls into.


SZSE:301393
92GF Score
Suzhou Highfine Biotech Co Ltd SZSE:301393
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Suzhou Highfine Biotech Co (SZSE:301393) Overvalued in 2026?

Based on GuruFocus' analysis, Suzhou Highfine Biotech Co stock appears to be undervalued. The current stock price of ¥60.06 is trading 15.1% below its estimated GF Value™ of ¥70.76. GuruFocus considers Suzhou Highfine Biotech Co to be Modestly Undervalued.

Key valuation signals for SZSE:301393:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: ¥70.76 vs. price of ¥60.06 (15.1% below fair value)
  • GF Score™: 92/100 with 6 warning signs

No single metric tells the full story. See the SZSE:301393 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Suzhou Highfine Biotech Co Business Description

Address No. 32 Hongxi Road, F-12 Standard Factory Building, High-tech Zone, Jiangsu Province, Suzhou, CHN, 215151
Suzhou Highfine Biotech Co Ltd is a high-tech enterprise that provides characteristic raw materials for global pharmaceutical research and development and raw material drug production companies. The products are mainly used in the fields of peptide, nucleotide and pharmaceutical synthesis. The product range covers peptide synthesis reagents for characteristic amide bond formation, molecular building blocks, protein reagents, liposome and lipid nanoparticle pharmaceutical reagents, ionic liquids , PROTAC reagents and nucleotide reagents and other types.
92GF Score

Get the complete analysis for SZSE:301393

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥60.06
Price
¥70.76
GF Value